236 related articles for article (PubMed ID: 18463325)
1. Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy.
Lv J; Zhang H; Cui Z; Su T; Zhang Y; Wang H
Nephrol Dial Transplant; 2008 Sep; 23(9):2868-72. PubMed ID: 18463325
[TBL] [Abstract][Full Text] [Related]
2. Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy.
Wan QJ; Hu HF; He YC; Luan SD; Chen HT; Liu HP; Li T; Xu Y; Xu HL; Liao Y
Kaohsiung J Med Sci; 2015 Jan; 31(1):42-6. PubMed ID: 25600919
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
[TBL] [Abstract][Full Text] [Related]
4. Retrospective study of mycophenolate mofetil treatment in IgA nephropathy with proliferative pathological phenotype.
Liang Y; Zhang J; Liu D; Quan S; Xing G; Liu Z
Chin Med J (Engl); 2014; 127(1):102-8. PubMed ID: 24384432
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
6. [A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy].
Chen X; Chen P; Cai G; Wu J; Cui Y; Zhang Y; Liu S; Tang L
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):796-801. PubMed ID: 12126522
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severe IgA nephropathy: mycophenolate mofetil/prednisone compared to cyclophosphamide/prednisone.
Liu X; Dewei D; Sun S; Xu G; Liu H; He L; Zhang P
Int J Clin Pharmacol Ther; 2014 Feb; 52(2):95-102. PubMed ID: 24161158
[TBL] [Abstract][Full Text] [Related]
8. Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases.
Zhang Y; Zheng Y
Rheumatol Int; 2014 Dec; 34(12):1765-71. PubMed ID: 24948376
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolic acid therapy after cyclophosphamide pulses in progressive IgA nephropathy.
Rasche FM; Keller F; von Müller L; Sailer LK; Karges W; Czock D
J Nephrol; 2006; 19(4):465-72. PubMed ID: 17048204
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review.
Chen Y; Li Y; Yang S; Li Y; Liang M
BMC Nephrol; 2014 Dec; 15():193. PubMed ID: 25475967
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil may protect against Pneumocystis carinii pneumonia in renal transplanted patients.
Azevedo LS; Castro MC; Paula FJ; Ianhez LE; David-Neto E
Rev Inst Med Trop Sao Paulo; 2005; 47(3):143-5. PubMed ID: 16021287
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.
Hogg RJ; Bay RC; Jennette JC; Sibley R; Kumar S; Fervenza FC; Appel G; Cattran D; Fischer D; Hurley RM; Cerda J; Carter B; Jung B; Hernandez G; Gipson D; Wyatt RJ
Am J Kidney Dis; 2015 Nov; 66(5):783-91. PubMed ID: 26209543
[TBL] [Abstract][Full Text] [Related]
14. Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.
Ye WL; Tang N; Wen YB; Li H; Li MX; Du B; Li XM
Int Urol Nephrol; 2016 Nov; 48(11):1863-1871. PubMed ID: 27351666
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose Corticosteroid Combined With Mycophenolate Mofetil for IgA Nephropathy With Stage 3 or 4 CKD: A Retrospective Cohort Study.
Zhao J; Ma F; Bai M; Sun S
Clin Ther; 2021 May; 43(5):859-870. PubMed ID: 33863547
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil treatment for therapy-resistant glomerulopathies.
Sahin GM; Sahin S; Kantarci G; Ergin H
Nephrology (Carlton); 2007 Jun; 12(3):285-8. PubMed ID: 17498124
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with mycophenolate mofetil and prednisone in steroid-resistant idiopathic membranoproliferative glomerulonephritis.
Yuan M; Zou J; Zhang X; Liu H; Teng J; Zhong Y; Ding X
Clin Nephrol; 2010 May; 73(5):354-9. PubMed ID: 20420795
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.
Hu W; Liu Z; Chen H; Tang Z; Wang Q; Shen K; Li L
Chin Med J (Engl); 2002 May; 115(5):705-9. PubMed ID: 12133539
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial.
Frisch G; Lin J; Rosenstock J; Markowitz G; D'Agati V; Radhakrishnan J; Preddie D; Crew J; Valeri A; Appel G
Nephrol Dial Transplant; 2005 Oct; 20(10):2139-45. PubMed ID: 16030050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
